V Bryan Lawlis Biomarin Pharmaceutical Inc (BMRN) insider trading activity

BMRN Quotes by TradingView

V Bryan Lawlis is Director of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 33,140 shares of BMRN, which is worth approximately $2.21 Million. The most recent transaction as insider was on May 23, 2023, when has been sold 4,190 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.1K
0% 3M change
0% 12M change
Total Value Held $2.21 Million

V BRYAN LAWLIS Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2023
BUY
Grant, award, or other acquisition
-
4,190 Added 11.22%
33,140 Common Stock
Apr 03 2023
SELL
Open market or private sale
$825,265 $97.09 p/Share
8,500 Reduced 22.7%
28,950 Common Stock
Apr 03 2023
BUY
Exercise of conversion of derivative security
$576,385 $67.81 p/Share
8,500 Added 18.5%
37,450 Common Stock
May 24 2022
BUY
Grant, award, or other acquisition
-
4,980 Added 14.68%
28,950 Common Stock
Apr 14 2022
SELL
Open market or private sale
$355,555 $83.66 p/Share
4,250 Reduced 15.06%
23,970 Common Stock
Apr 14 2022
BUY
Exercise of conversion of derivative security
$159,205 $37.46 p/Share
4,250 Added 13.09%
28,220 Common Stock
Jan 14 2022
SELL
Open market or private sale
$372,343 $87.61 p/Share
4,250 Reduced 15.06%
23,970 Common Stock
Jan 14 2022
BUY
Exercise of conversion of derivative security
$159,205 $37.46 p/Share
4,250 Added 13.09%
28,220 Common Stock
May 25 2021
BUY
Grant, award, or other acquisition
-
5,120 Added 17.6%
23,970 Common Stock
Apr 15 2021
SELL
Open market or private sale
$576,750 $76.9 p/Share
7,500 Reduced 28.46%
18,850 Common Stock
Apr 15 2021
BUY
Exercise of conversion of derivative security
$198,675 $26.49 p/Share
7,500 Added 22.16%
26,350 Common Stock
Feb 16 2021
SELL
Open market or private sale
$655,575 $87.41 p/Share
7,500 Reduced 28.46%
18,850 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$198,675 $26.49 p/Share
7,500 Added 22.16%
26,350 Common Stock

Also insider at

HGEN
HUMANIGEN, INC Healthcare
Director
CHRS
Coherus BioSciences, Inc. Healthcare
Director
GERN
GERON CORP Healthcare
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
Director
VBL

V Bryan Lawlis

Director
South San Francisco, CA

Track Institutional and Insider Activities on BMRN

Follow BIOMARIN PHARMACEUTICAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BMRN